Australian shares rose on Tuesday, driven by technology and healthcare stocks, although a sharp drop in biotech firm Mesoblast due to disappointing earnings kept a lid on gains.
The S&P/ASX 200 index climbed 0.4% to end at 7,534.9, its highest close since…

Click here to view the original article.